MENU
YMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Y-mAbs Therapeutics (YMAB) Ownership - Who owns Y-mAbs Therapeutics?
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
217.05M
P/E Ratio
N/A
Total Cash
67.23M
Projected Growth
N/A
Total Debt
820K
Revenue
87.69M
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash/Share
1.49
Total Debt/Equity
N/A
Revenue/Share
1.98 USD as % of share price
Fundamentals
YMAB
Capitalization
217M
P/E Ratio
N/A
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash
67.2M
Total Cash/Share
1.49
Total Debt
820K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.98%
Revenue
87.7M
ROE
N/A
Book Value
92M
P/B Ratio
2.36
Cash Flow
N/A
Earnings
-0.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
4.16
Current Revenue Per Employee
247616.83
Dividends Per Share - Security
N/A
EBITDA
-30.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
70.40
Revenue To Assets
-23.95
Shares Held By Institutions
301M
Shares Outstanding - Current
45.2M
Total Liabilities
27.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.697
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com